Private Capital Group, LLC - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 222 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2022. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Capital Group, LLC ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2022$12,000
-20.0%
2060.0%0.01%
+200.0%
Q1 2022$15,000
-16.7%
206
-1.0%
0.00%
-25.0%
Q4 2021$18,000
-5.3%
208
+1.0%
0.00%0.0%
Q3 2021$19,000
-5.0%
206
-1.0%
0.00%
-20.0%
Q2 2021$20,000
-16.7%
208
-3.3%
0.01%
-16.7%
Q1 2021$24,000
-68.0%
215
-60.2%
0.01%
-57.1%
Q4 2020$75,000
+70.5%
540
-0.2%
0.01%
+55.6%
Q3 2020$44,000
+7.3%
541
+2.5%
0.01%0.0%
Q2 2020$41,000
+78.3%
528
+3.9%
0.01%
+50.0%
Q1 2020$23,000
+64.3%
508
+52.1%
0.01%
+100.0%
Q4 2019$14,000
+600.0%
334
+882.4%
0.00%
Q3 2019$2,000
-33.3%
340.0%0.00%
-100.0%
Q2 2019$3,000
+50.0%
340.0%0.00%
Q1 2019$2,000
+100.0%
340.0%0.00%
Q4 2018$1,000
-50.0%
340.0%0.00%
Q3 2018$2,0000.0%340.0%0.00%
Q2 2018$2,0000.0%340.0%0.00%
Q1 2018$2,0000.0%34
-97.7%
0.00%
Q4 2017$2,0001,5000.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2022
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 497,899$31,617,0003.20%
HIGHLINE CAPITAL MANAGEMENT, L.P. 390,453$24,794,0001.81%
First Light Asset Management, LLC 180,017$11,431,0001.59%
Rock Springs Capital Management LP 580,000$36,830,0001.33%
Capital Impact Advisors, LLC 36,165$2,244,0000.82%
SECTOR GAMMA AS 79,653$5,058,0000.81%
Verity Asset Management, Inc. 7,193$457,0000.51%
Opus Point Partners Management, LLC 5,064$322,0000.48%
Capital International Sarl 52,000$3,302,0000.46%
PACIFIC VIEW ASSET MANAGEMENT, LLC 6,216$394,0000.43%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders